Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PFIZER INCPFE · Entity 2863 | President, Global Biopharma | May 10, 2023 | May 11, 2023 |
| UNITED PARCEL SERVICE INCUPS · Entity 2301 | Director | May 07, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PFIZER INC
Report date May 10, 2023 · Filed May 11, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 69,046 |
Reported balance
After 2023-05-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-05-10 · Other · Acquired 33,943 · Balance 69,046 F1: Each unit represents one phantom share of common stock. F2: This transaction constitutes an intra-plan transfer to acquire Pfizer stock units in the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. F3: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: This transaction constitutes an intra-plan transfer to acquire Pfizer stock units in the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan.
F3: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
UNITED PARCEL SERVICE INC
Report date May 07, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,362.7884 |
Reported balance
After 2026-05-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 1,948 · Balance 10,362.7884 F1: One unit is equivalent to one share of UPS Class A common stock. F2: Restricted stock units convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3: Includes units credited upon the payment of dividends on the underlying Class A common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: One unit is equivalent to one share of UPS Class A common stock.
F2: Restricted stock units convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director.
F3: Includes units credited upon the payment of dividends on the underlying Class A common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 14,493 | $34.59 | $501,312.87 |
DisclosureSEC source: 0001225208-20-003799 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 23, 2020 Filed Feb 25, 2020 23:03 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,409 | $35.72 | $50,329.48 |
DisclosureSEC source: 0001225208-20-003500 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,977 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). F2 · price: Price is the closing price of Pfizer common stock on February 21, 2020. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 15:44 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 216 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015129 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 8,532 Read SEC document |
| August 30, 2019 Filed Sep 3, 2019 22:02 UTC | PFIZER INC PFE · Entity 2863 | OtherPhantom Stock Units SSP · Derivative | 13,142 | $35.55 | $467,198.10 |
DisclosureSEC source: 0001225208-19-012057 · doc4.xml · derivative · entry 4 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,540 Underlying: Common Stock · 13,142 shares Expires not disclosed F3 · derivative.exercise_price: Each unit represents one phantom share of common stock. F4 · shares: This transaction constitutes an intra-plan transfer into the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. F5 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F5 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 30, 2019 Filed Sep 3, 2019 22:02 UTC | PFIZER INC PFE · Entity 2863 | OtherCommon Stock | 9,896 | $35.55 | $351,802.80 |
DisclosureSEC source: 0001225208-19-012057 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By Rule 16b-3 Plan Disclosed balance after: 13,079 F1 · shares: This transaction constitutes an intra-plan transfer into the Pfizer Inc. stock fund under the Pfizer's Qualified Savings Plan. Read SEC document |
| May 29, 2019 Filed Sep 3, 2019 22:02 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-012057 · doc4.xml · nonDerivative · entry 2 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 8,748 F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares held by spouse. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 101,409 | $0.00 Strike: $43.35 | $0.00 |
DisclosureSEC source: 0001225208-19-004212 · doc4.xml · derivative · entry 10 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,409 Underlying: Common Stock · 101,409 shares Expires 2026-02-28 F8 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F8 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 120,335 | $0.00 Strike: $43.35 | $0.00 |
DisclosureSEC source: 0001225208-19-004212 · doc4.xml · derivative · entry 9 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,335 Underlying: Common Stock · 120,335 shares Expires 2024-02-28 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 11,792 | $0.00 Strike: $32.23 | $0.00 |
DisclosureSEC source: 0001225208-19-004212 · doc4.xml · derivative · entry 8 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,792 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 7,283 | $42.31 | $308,143.73 |
DisclosureSEC source: 0001225208-19-004212 · doc4.xml · nonDerivative · entry 5 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,230 F5 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F6 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 2,270 | $42.93 | $97,451.10 |
DisclosureSEC source: 0001225208-19-004212 · doc4.xml · nonDerivative · entry 4 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,513 F4 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,532 | $42.93 | $65,768.76 |
DisclosureSEC source: 0001225208-19-004212 · doc4.xml · nonDerivative · entry 3 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,783 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 6,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-004212 · doc4.xml · nonDerivative · entry 2 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,315 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 11,792 | $32.23 | $380,056.16 |
DisclosureSEC source: 0001225208-19-004212 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 00:11 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,565 | $43.08 | $67,420.20 |
DisclosureSEC source: 0001225208-19-003776 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,843 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 00:38 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 976 | $37.09 | $36,199.84 |
DisclosureSEC source: 0001225208-18-004458 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,280 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 23:05 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,463 | $37.09 | $54,262.67 |
DisclosureSEC source: 0001225208-18-004662 · doc4.xml · nonDerivative · entry 2 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,121 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 23:05 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 4,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-004662 · doc4.xml · nonDerivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,560 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 20:50 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 45,297 | $0.00 Strike: $35.74 | $0.00 |
DisclosureSEC source: 0001225208-18-003968 · doc4.xml · derivative · entry 2 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,297 Underlying: Common Stock · 45,297 shares Expires 2025-02-22 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 20:50 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 54,182 | $0.00 Strike: $35.74 | $0.00 |
DisclosureSEC source: 0001225208-18-003968 · doc4.xml · derivative · entry 1 Hwang Angela · CIK 0001725474 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,182 Underlying: Common Stock · 54,182 shares Expires 2023-02-22 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.